Literature DB >> 20688159

Akt isoform-specific inhibition of MDA-MB-231 cell proliferation.

Wonseok Yang1, Ji-hyun Ju, Kyung-min Lee, Incheol Shin.   

Abstract

To dissect the isoform-specific roles of Akt in breast cancer cells, constitutively active Akt isoforms were introduced into MDA-MB-231 cells. Both Akt1 and Akt2 efficiently inhibited the growth of MDA-MB-231 cells. Overexpression of Akt1 down-regulated ERK activity inhibiting Ser 259 phosphorylation of c-Raf and subsequent downstream signaling. Akt2 overexpression up-regulated the cell cycle inhibitor p27. Cycloheximide decay assays showed that Akt2 increased the stability and nuclear localization of p27, thus inhibiting the cyclin E/CDK2 complex. These results suggest that the inhibition of cell proliferation by Akt1 and Akt2 is mediated by isoform-specific mechanisms.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20688159     DOI: 10.1016/j.cellsig.2010.07.016

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  10 in total

1.  Regulation of IKKε Expression by Akt2 Isoform.

Authors:  Soumya Krishnamurthy; Alakananda Basu
Journal:  Genes Cancer       Date:  2011-11

2.  Contribution of xanthine oxidoreductase to mammary epithelial and breast cancer cell differentiation in part modulates inhibitor of differentiation-1.

Authors:  Mehdi A Fini; Jenifer Monks; Susan M Farabaugh; Richard M Wright
Journal:  Mol Cancer Res       Date:  2011-07-20       Impact factor: 5.852

3.  Identification and quantification of AKT isoforms and phosphoforms in breast cancer using a novel nanofluidic immunoassay.

Authors:  Demetris C Iacovides; Aimee B Johnson; Nick Wang; Shanta Boddapati; Jim Korkola; Joe W Gray
Journal:  Mol Cell Proteomics       Date:  2013-08-08       Impact factor: 5.911

4.  Ablation of Akt2 induces autophagy through cell cycle arrest, the downregulation of p70S6K, and the deregulation of mitochondria in MDA-MB231 cells.

Authors:  Stacey A Santi; Hoyun Lee
Journal:  PLoS One       Date:  2011-01-31       Impact factor: 3.240

5.  Differential effects of the phosphatidylinositol 4-kinases, PI4KIIα and PI4KIIIβ, on Akt activation and apoptosis.

Authors:  K M E Chu; S Minogue; J J Hsuan; M G Waugh
Journal:  Cell Death Dis       Date:  2010       Impact factor: 8.469

6.  Curcumin Suppresses Proliferation and Migration of MDA-MB-231 Breast Cancer Cells through Autophagy-Dependent Akt Degradation.

Authors:  Feng Guan; Youming Ding; Yemin Zhang; Yu Zhou; Mingxin Li; Changhua Wang
Journal:  PLoS One       Date:  2016-01-11       Impact factor: 3.240

7.  Integrated analysis of promoter mutation, methylation and expression of AKT1 gene in Chinese breast cancer patients.

Authors:  Jianfu Heng; Xinwu Guo; Wenhan Wu; Yue Wang; Guoli Li; Ming Chen; Limin Peng; Shouman Wang; Lizhong Dai; Lili Tang; Jun Wang
Journal:  PLoS One       Date:  2017-03-16       Impact factor: 3.240

Review 8.  Distinct functions of AKT isoforms in breast cancer: a comprehensive review.

Authors:  Nico Hinz; Manfred Jücker
Journal:  Cell Commun Signal       Date:  2019-11-21       Impact factor: 5.712

9.  Loss of Akt1 or Akt2 delays mammary tumor onset and suppresses tumor growth rate in MTB-IGFIR transgenic mice.

Authors:  Katrina L Watson; Roger A Moorehead
Journal:  BMC Cancer       Date:  2013-08-07       Impact factor: 4.430

10.  Akt inhibition attenuates rasfonin-induced autophagy and apoptosis through the glycolytic pathway in renal cancer cells.

Authors:  Q Lu; S Yan; H Sun; W Wang; Y Li; X Yang; X Jiang; Y Che; Z Xi
Journal:  Cell Death Dis       Date:  2015-12-03       Impact factor: 8.469

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.